The Neuroendocrine Tumor (NET) Patient (pt) Perspective: Results from the First Global NET Pt Survey - A Collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis Pharmaceuticals

R3

  • Leyden, J.
  • Sissons, M.
  • Goldstein, G.
  • Kolarova, T.
  • Bouvier, C.

  • aThe Unicorn Foundation, Mosman, Australia;

    bNET Patient Foundation, Hockley Heath, UK;

    cThe Carcinoid Cancer Foundation, White Plains, USA;

    dAPOZ & Friends, Sofia, Bulgaria

Neuroendocrinology 102(2):p 158-159, September-October 2015.
Copyright © 2015 S. Karger AG, Basel
View full text|Download PDF